Molbio Diagnostics IPO Allotment Today: Check Status as GMP Signals Strong Listing
Source: Mint Markets
Arth Insight · What this means for your wallet
- A 70.26x oversubscription means high competition; if you aren't allotted shares, expect your blocked funds (₹14,000-₹15,000 per lot) to be released by August 14.
- The ₹156 Grey Market Premium suggests a potential profit of approximately 20-30% over the issue price on listing day.
- Successful allottees should decide between booking quick listing gains or holding for long-term growth before the August 17 debut.
The allotment for Molbio Diagnostics IPO is set for finalization today, August 13, following a massive 70.26x subscription. Investors can check their status online as the grey market premium suggests a positive debut on the stock exchanges.
- ▸Molbio Diagnostics IPO allotment is expected to be finalized today, August 13.
- ▸The issue was oversubscribed by over 70 times, indicating high investor interest.
- ▸The current Grey Market Premium (GMP) of ₹156 suggests a strong listing on August 17.
- ▸Investors can check status via Kfin Technologies using PAN or Application number.
- ✓Molbio Diagnostics IPO allotment is expected to be finalized today, August 13.
- ✓The issue was oversubscribed by over 70 times, indicating high investor interest.
- ✓The current Grey Market Premium (GMP) of ₹156 suggests a strong listing on August 17.
- ✓Investors can check status via Kfin Technologies using PAN or Application number.
Investors who applied for the Molbio Diagnostics IPO can expect the share allotment process to be finalized today, August 13. The public issue received an overwhelming response from the market, being oversubscribed 70.26 times by the close of the bidding period. This high demand indicates a competitive allocation process for retail and institutional investors alike.
How to Check Allotment Status
The registrar for the Molbio Diagnostics IPO is Kfin Technologies Limited. Investors can verify their allotment status by visiting the Kfin Technologies portal or the official websites of the BSE and NSE. You will typically need your PAN card number, application number, or DP ID to access the results. Once the allotment is finalized, the company will initiate refunds for unsuccessful bidders on August 14, while shares will be credited to the demat accounts of successful applicants by August 16.
Grey Market Premium and Listing Expectations
Market sentiment remains bullish for Molbio Diagnostics. As of today, the Grey Market Premium (GMP) is hovering around ₹156. The GMP is an unofficial indicator of the premium investors are willing to pay over the issue price before the shares officially list. Based on the current GMP and the strong subscription numbers, analysts expect a robust debut when the shares list on the exchanges, scheduled for August 17.
What This Means for Retail Investors
The 70.26x subscription means that the chances of receiving a full allotment are slim for most retail applicants due to the lottery-based system used for oversubscribed issues. If you are allotted shares, the current grey market trends suggest a potential for listing gains. However, investors should remember that GMP is not a guaranteed indicator of listing day performance and should focus on the company's long-term fundamentals.
- Allotment Date: August 13
- Refund Initiation: August 14
- Demat Credit: August 16
- Listing Date: August 17
This report is for informational purposes only and does not constitute financial or investment advice.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.
Frequently Asked Questions
Where can I check the Molbio Diagnostics IPO allotment status?
You can check the status on the Kfin Technologies website (the registrar) or the BSE/NSE websites using your PAN or application number.
What happens if I don't get an allotment?
If you are not allotted shares, the refund process will be initiated on August 14, and the blocked funds in your bank account will be released.
When will Molbio Diagnostics shares list on the stock exchange?
The shares are scheduled to be listed on the BSE and NSE on August 17.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Stock Market
BreakingStock Markets (BSE, NSE) Closed March 3, 2026 for Holi: Trading & Settlement Holiday Announced
Indian stock exchanges, BSE and NSE, will observe a trading and settlement holiday on Tuesday, March 3, 2026, in observance of Holi. All segments, including equity, derivatives, currency, and commodities, will remain closed, impacting financial transactions and trade settlements.
Credit Weekly Warns Indian Corporates: Bond Resilience May End Amid Global Selloff
A 'rate market fear gauge' is signaling that the current resilience of corporate bonds, even amidst a global government bond selloff, may not last. This warning, highlighted by Credit Weekly via Mint Markets, suggests that Indian companies could soon face higher borrowing costs for funds raised in the debt market.
India's Stock Exchange Competition Intensifies, The Economist Reports
A report by The Economist indicates heightened competition among India's stock exchanges. Specific details regarding the nature and implications of this competitive escalation are not available in the provided information.
Related Stories
BreakingStock Markets (BSE, NSE) Closed March 3, 2026 for Holi: Trading & Settlement Holiday Announced
Indian stock exchanges, BSE and NSE, will observe a trading and settlement holiday on Tuesday, March 3, 2026, in observance of Holi. All segments, including equity, derivatives, currency, and commodities, will remain closed, impacting financial transactions and trade settlements.
Credit Weekly Warns Indian Corporates: Bond Resilience May End Amid Global Selloff
A 'rate market fear gauge' is signaling that the current resilience of corporate bonds, even amidst a global government bond selloff, may not last. This warning, highlighted by Credit Weekly via Mint Markets, suggests that Indian companies could soon face higher borrowing costs for funds raised in the debt market.
India's Stock Exchange Competition Intensifies, The Economist Reports
A report by The Economist indicates heightened competition among India's stock exchanges. Specific details regarding the nature and implications of this competitive escalation are not available in the provided information.
BreakingCompetition Heats Up Between India's Top Stock Exchanges, The Economist Notes
According to a report by The Economist, the rivalry between India's leading stock exchanges is intensifying. This increased competition typically drives innovation, potentially leading to better services and lower costs for investors and market participants.